01 9Aspirin Cardio
02 1AspirinTM Cardio
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 773
2019 Revenue in Millions : 700
Growth (%) : 10
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 746
2020 Revenue in Millions : 773
Growth (%) : 6
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 827
2021 Revenue in Millions : 746
Growth (%) : 11
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 679
2022 Revenue in Millions : 827
Growth (%) : -21
Main Therapeutic Indication : Cardiovascular
Currency : USD
2015 Revenue in Millions : 535
2014 Revenue in Millions : 576
Growth (%) : 8%
Main Therapeutic Indication : Cardiovascular
Currency : USD
2014 Revenue in Millions : 7.50%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 720
2016 Revenue in Millions : 667
Growth (%) : 8
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 570
2015 Revenue in Millions : 555
Growth (%) : 3
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 629
2017 Revenue in Millions : 657
Growth (%) : -4%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 631
2018 Revenue in Millions : 607
Growth (%) : 4
LOOKING FOR A SUPPLIER?